Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Exquim is a Spanish chemical-pharmaceutical company specializing in the development and manufacture of active pharmaceutical ingredients (APIs) and fine chemicals. As a subsidiary of the Ferrer group, the company operates state-of-the-art manufacturing facilities that comply with international GMP standards. Exquim provides a wide range of products including cardiovascular agents, anti-inflammatories, and nutraceutical ingredients like chondroitin sulfate and glucosamine. The company offers contract development and manufacturing services (CDMO) to global pharmaceutical and healthcare partners. Its expertise spans complex chemical synthesis and large-scale production for both human and animal health markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EXQUIM.